1 of 2 marimastat trials clears hurdle

British Biotech (LSE:BBG; BBIOY) said interim analyses of two Phase III trials of its marimastat oral matrix metalloproteinase inhibitor (MMPI) resulted in the termination of one of the trials in non-...